Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

Neurobiology of Disease

Volumn 32, Issue 3, 2008, Pages 412-419

  Edison, Paul ^a   Archer, Hilary A ^b   Gerhard, Alexander ^a,d   Hinz, Rainer ^c,d   Pavese, Nicola ^a   Turkheimer, Federico E ^a   Hammers, Alexander ^a   Tai, Yen Fong ^a   Fox, Nick ^b   Kennedy, Angus ^a   Rossor, Martin ^a,b   Brooks, David J ^a,c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GE HEALTHCARE   (Germany)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alzheimer; Amyloid; Microglia; PET; PIB; PK11195

Indexed keywords

AMYLOID PROTEIN; CARBON 11; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL ACTIVATION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; MALE; MICROGLIA; MINI MENTAL STATE EXAMINATION; NERVE CELL LESION; OCCIPITAL LOBE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TEMPORAL LOBE;

AGED; ALZHEIMER DISEASE; AMYLOID; ANILINE COMPOUNDS; CARBON RADIOISOTOPES; CEREBRAL CORTEX; CLUSTER ANALYSIS; COGNITION; FEMALE; HUMANS; ISOQUINOLINES; MAGNETIC RESONANCE IMAGING; MALE; MICROGLIA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; THIAZOLES;

EID: 56349144614     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.08.001     Document Type: Article

References (53)

1. Akiyama H., et al. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
2. Anderson A.N., et al. A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195. Neuroimage 36 (2007) 28-37
3. Archer H.A., et al. Amyloid load and cerebral atrophy in Alzheimer's disease: An (11)C-PIB positron emission tomography study. Ann. Neurol. 60 (2006) 145-147
4. Banati R.B., et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 Pt 11 (2000) 2321-2337
5. Bard F., et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6 (2000) 916-919
6. Beurdeley-Thomas A., et al. The peripheral benzodiazepine receptors: a review. J. Neurooncol. 46 (2000) 45-56
7. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl). 82 (1991) 239-259
8. Brix G., et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J. Nucl. Med. 38 (1997) 1614-1623
9. Cagnin A., et al. In-vivo measurement of activated microglia in dementia. Lancet. 358 (2001) 461-467
10. Cagnin A., et al. In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124 (2001) 2014-2027
11. DiPatre P.L., and Gelman B.B. Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. J. Neuropathol. Exp. Neurol. 56 (1997) 143-149
12. Edison P., et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 68 (2007) 501-508
13. Eikelenboom P., et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia 40 (2002) 232-239
14. Engler H., et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129 (2006) 2856-2866
15. Fagan A.M., et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann. Neurol. 59 (2006) 512-519
16. Frackowiak J., et al. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol. (Berl). 84 (1992) 225-233
17. Frautschy S.A., et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152 (1998) 307-317
18. Giulian D., et al. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16 (1996) 6021-6037
19. Graeber M.B., et al. Synaptic stripping in the human facial nucleus. Acta Neuropathol. 86 (1993) 179-181
20. Hammers A., et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 19 (2003) 224-247
21. Hardy J., and Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12 (1991) 383-388
22. Klunk W.E., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55 (2004) 306-319
23. Klunk W.E., et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129 (2006) 2805-2807
24. Klunk W.E., et al. The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J. Neurosci. 23 (2003) 2086-2092
25. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
26. Larner A.J. The cerebellum in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 8 (1997) 203-209
27. Lopresti B.J., et al. Simplified quantification of Pittsburgh compound B Amyloid imaging PET studies: a comparative analysis. J. Nucl. Med. 46 (2005) 1959-1972
28. Lue L.F., et al. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35 (2001) 72-79
29. Mann D.M. Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome. Neurobiol. Aging 10 (1989) 397-399 discussion 412-4
30. Mattiace L.A., et al. Microglia in cerebellar plaques in Alzheimer's disease. Acta Neuropathol. (Berl). 80 (1990) 493-498
31. McDonald D.R., et al. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17 (1997) 2284-2294
32. McGeer P.L., and McGeer E.G. Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22 (2001) 799-809
33. McGeer P.L., and McGeer E.G. Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 8 (2002) 529-538
34. McKhann G., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
35. Meda L., et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374 (1995) 647-650
36. Mintun M.A. Utilizing advanced imaging and surrogate markers across the spectrum of Alzheimer's disease. CNS Spectr. 10 (2005) 13-16
37. Parola A.L., et al. Peripheral-type benzodiazepine receptors. Life Sci. 52 (1993) 1329-1342
38. Price J.C., et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J. Cereb. Blood Flow Metab. 25 (2005) 1528-1547
39. Rogers J., et al. Elucidating molecular mechanisms of Alzheimer's disease in microglial cultures. Ernst Schering Res. Found. Workshop (2002) 25-44
40. Schenk D., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
41. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
42. Shah F., et al. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl. Med. Biol. 21 (1994) 573-581
43. Spinks T.J., et al. Physical characteristics of the ECAT EXACT3D positron tomograph. Phys. Med. Biol. 45 (2000) 2601-2618
44. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40 (2002) 133-139
45. Streit W.J. Microglia and Alzheimer's disease pathogenesis. J. Neurosci. Res. 77 (2004) 1-8
46. Teller J.K., et al. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat. Med. 2 (1996) 93-95
47. Turkheimer F.E., et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J. Nucl. Med. 48 (2007) 158-167
48. Vehmas A.K., Stewart W.F., and Troncoso J.C. Immune reactive cells in senile plaques and cognitive decline in AD. Neurobiol. Aging 24 (2003) 321-331
49. Verhoeff N.P., et al. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am. J. Geriatr. Psychiatry 12 (2004) 584-595
50. Wisniewski H.M., et al. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci. 16 (1989) 535-542
51. Wisniewski H.M., et al. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol. (Berl). 84 (1992) 117-127
52. Wisniewski T., et al. Lewy bodies are immunoreactive with antibodies raised to gelsolin related amyloid-Finnish type. Am. J. Pathol. 138 (1991) 1077-1083
53. Yoshiyama Y., et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53 (2007) 337-351